Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA Tags Coronary artery disease DPP-4 inhibitors Rheumatoid Arthritis (RA) SGLT-2 Inhibitor Read more about Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA
SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM
Metformin Showed No Overall Difference in Parkinsonism Risk Tags Biguanide DPP-4 inhibitors Diabetic Neuropathy Read more about Metformin Showed No Overall Difference in Parkinsonism Risk
Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i Tags DPP-4 inhibitors GLP-1 agonists SGLT-2 Inhibitor Read more about Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i
GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM Tags Biguanide Continuous glucose monitoring (CGM) DPP-4 inhibitors GLP-1 agonists Hypoglycemia Long acting Sulphonylureas hBA1c Read more about GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM
Dapagliflozin-Linagliptin Combination Improved TIR in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about Dapagliflozin-Linagliptin Combination Improved TIR in T2DM
Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM Tags hBA1c Sulphonylureas DPP-4 inhibitors Biguanide Read more about Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM
GLP-1RAs Linked to Lower MACE Risk in Dialysis With T2DM Tags Coronary artery disease GLP-1 agonists DPP-4 inhibitors Read more about GLP-1RAs Linked to Lower MACE Risk in Dialysis With T2DM
Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM